Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gutierrez

Showing results (971-980 of 1,001) with videos related to

Pageof 101
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 MutationBhavana V Chapman, Diane Liu, Yu Shen, et al.
Journal of the American Medical Directors Association|June 15, 2013
Frailty consensus: a call to actionJohn E Morley, Bruno Vellas, G Abellan van Kan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2021
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel TestingBhavana V Chapman, Diane Liu, Yu Shen, et al.
Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
JCI Insight|June 23, 2025
The distal nephron biomarkers associate with diabetic kidney disease progressionChristina L Tamargo, Steven G Coca, Heather Thiessen Philbrook, et al.
Cell Reports. Medicine|December 17, 2025
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancerJody Vykoukal, Yihui Chen, Mingxin Zuo, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.
Annals of Hematology|March 7, 2025
Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a case reportGéssika B G M Gutierrez de Moraes Pereira, Victor A Rocha, Paulo Victor R Barbosa, et al.
The Journal of Cell Biology|December 8, 2004
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcomaDavid M Thomas, Sandra A Johnson, Natalie A Sims, et al.
Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.
Pageof 101

Showing results (971-980 of 1,001) with videos related to

Sort By:
Pageof 101
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 MutationBhavana V Chapman, Diane Liu, Yu Shen, et al.
Journal of the American Medical Directors Association|June 15, 2013
Frailty consensus: a call to actionJohn E Morley, Bruno Vellas, G Abellan van Kan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2021
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel TestingBhavana V Chapman, Diane Liu, Yu Shen, et al.
Molecular Cancer Therapeutics|October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS studyJavier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
JCI Insight|June 23, 2025
The distal nephron biomarkers associate with diabetic kidney disease progressionChristina L Tamargo, Steven G Coca, Heather Thiessen Philbrook, et al.
Cell Reports. Medicine|December 17, 2025
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancerJody Vykoukal, Yihui Chen, Mingxin Zuo, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.
Annals of Hematology|March 7, 2025
Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a case reportGéssika B G M Gutierrez de Moraes Pereira, Victor A Rocha, Paulo Victor R Barbosa, et al.
The Journal of Cell Biology|December 8, 2004
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcomaDavid M Thomas, Sandra A Johnson, Natalie A Sims, et al.
Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.
Pageof 101